Officer sold ~$1.31M of Vertex Pharmaceuticals
Scheduled in advanceLoading…
Traded Feb 11, 2026 · Filed Feb 12, 2026
Vertex Pharmaceuticals's SVP & Chief Accounting Officer sold $634K of Vertex Pharmaceuticals shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$633,552
Shares × reported transaction price
100 days after results of Nov 3, 2025, 1 day before results of Feb 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $461.24 on Feb 11, 2026, 26% above its 52-week low and 10% below its high, little changed over the previous 30 trading days
52-week range $366.54 (Aug 8, 2025) to $513.76 (Mar 17, 2025), 64% of the way up, from 251 adjusted closes. 30 trading days earlier: $459.78 on Dec 29, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.0% | +1.1% | -4.1% |
| 30 days | -5.2% | -1.9% | -3.3% |
| 90 days | -8.3% | +9.7% | -18.1% |
| 180 days | +7.0% | +13.3% | -6.3% |
Past results only. Not a forecast.
Officer sold ~$1.31M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$1.16M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$442K of Vertex Pharmaceuticals
Scheduled in advance
